1. 2641 Comprehensive genomic profiling of advanced penile carcinoma suggests a high rate of clinically relevant genomic alterations. (September 2015) Authors: Ali, S.; Sanford, E.; Elvin, J.; Bailer, M.; He, J.; Wang, K.; Chmielecki, J.; Yelensky, R.; Morosini, D.; Lipson, D.; Frampton, G.; Chalmers, Z.; Stephens, P.; Ross, J.; Miller, V.; Pal, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2651 Comprehensive genomic profiling (CGP) identifies unique and abundant clinically relevant genomic alterations in rare histologies of renal cell carcinoma. (September 2015) Authors: Ali, S.; Choueiri, T.; Wang, K.; Khaira, D.; Johnson, A.; Squillace, R.; Elvin, J.; Chmielecki, J.; Yelensky, R.; Lipson, D.; Miller, V.; Ross, J.; Stein, M.; Pal, S.; Stephens, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2813 Comprehensive genomic profiling of clinically advanced medullary thyroid carcinoma. (September 2015) Authors: Heilmann, A.; Subbiah, V.; Wang, K.; Elvin, J.; Chmielecki, J.; Yelensky, R.; Vergilio, J.A.; Erlich, R.; Lipson, D.; Ross, J.; Miller, V.; Ali, S.; Stephens, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2879 High prevalent BRAF alterations and tert promoter mutations in papillary thyroid carcinoma. (September 2015) Authors: Wang, K.; Ganesan, S.; Johnson, A.; Sharman, J.P.; Chachoua, A.; Hirshfield, K.; Aisner, J.; Yelensky, R.; Lipson, D.; Elvin, J.A.; Chmielecki, J.; Stephens, P.J.; Ross, J.S.; Miller, V.A.; Ou, S.H.I.; Ali, S.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3007 Comprehensive genomic profiling characterizes the cpectrum of non-V600E activating BRAF alterations Including BRAF fusions in lung cancer. (September 2015) Authors: Ali, S.; Wang, K.; Johnson, A.; Suh, J.; Heilmann, A.; Lipson, D.; Yelensky, R.; Chmielecki, J.; Elvin, J.; Konduri, K.; Subbiah, V.; Stephens, P.; Ross, J.; Miller, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 464 Comprehensive genomic profiling of advanced cancers identifies MET exon 14 alterations that are sensitive to MET inhibitors. (September 2015) Authors: Frampton, G.; Ali, S.; Rosenzweig, M.; Chmielecki, J.; Bauer, T.; Akimov, M.; Peters, M.; Bufill, J.; Lee, C.; Ou, I.; Salgia, R.; Yelensky, R.; Morosini, D.; Ross, J.; Philip, S.; Miller, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 801 Therapeutically relevant extracellular domain mutations in ERBB2/HER2 are observed across multiple tumor types and are sssociated with major responses to anti-HER2 targeted therapies. (September 2015) Authors: Ross, J.; Chalmers, Z.; Wang, K.; Yelensky, R.; Lipson, D.; Elvin, J.; Vergilio, J.A.; Chmielecki, J.; Ali, S.; Miller, V.; Stephens, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗